RemeGen Co Ltd
HKEX:9995

Watchlist Manager
RemeGen Co Ltd Logo
RemeGen Co Ltd
HKEX:9995
Watchlist
Price: 78.3 HKD 2.09% Market Closed
Market Cap: 81.1B HKD

Relative Value

The Relative Value of one RemeGen Co Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 78.3 HKD, RemeGen Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RemeGen Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
48
vs Industry
37
Median 3Y
24.1
Median 5Y
20.4
Industry
7.8
Forward
17.2
vs History
vs Industry
Median 3Y
-24.2
Median 5Y
-20.4
Industry
24.1
Forward
-75.4
vs History
vs Industry
Median 3Y
-27.4
Median 5Y
-28
Industry
21.8
vs History
vs Industry
3
Median 3Y
-22.9
Median 5Y
-24.4
Industry
23.8
vs History
8
vs Industry
13
Median 3Y
8.8
Median 5Y
8.6
Industry
3.3
vs History
46
vs Industry
31
Median 3Y
24.6
Median 5Y
20.3
Industry
8
Forward
17.6
vs History
46
vs Industry
28
Median 3Y
29.6
Median 5Y
25.1
Industry
10.3
vs History
vs Industry
Median 3Y
-25.3
Median 5Y
-21.3
Industry
6.3
Forward
-182.9
vs History
vs Industry
Median 3Y
-25.3
Median 5Y
-21.3
Industry
6.7
Forward
-97.6
vs History
vs Industry
Median 3Y
-26.9
Median 5Y
-27.5
Industry
7.9
vs History
vs Industry
Median 3Y
-16.8
Median 5Y
-17.7
Industry
6.3
vs History
34
vs Industry
31
Median 3Y
7.4
Median 5Y
7.5
Industry
5.5

Multiples Across Competitors

Competitors Multiples
RemeGen Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
RemeGen Co Ltd
HKEX:9995
46.4B HKD 20.8 -49 -55.9 -55.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 873 393.2 -160 995.2 -195 499.5 -193 268.7
US
Abbvie Inc
NYSE:ABBV
400.9B USD 6.7 170.7 16.5 23.4
US
Amgen Inc
NASDAQ:AMGN
176.1B USD 4.9 25.1 18.1 18.1
US
Gilead Sciences Inc
NASDAQ:GILD
154.4B USD 5.3 19 12.8 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 9.9 31.5 23.1 24.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 079.8 -530.7 -577.9 -562.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.9B USD 5.7 17.7 16.8 19.1
AU
CSL Ltd
ASX:CSL
84.8B AUD 3.6 18.7 12.6 15.7
NL
argenx SE
XBRU:ARGX
45B EUR 14.6 34.4 59.4 61
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.7B USD 16.4 1 210.8 159.1 192.9
P/S Multiple
Revenue Growth P/S to Growth
CN
RemeGen Co Ltd
HKEX:9995
Average P/S: 3 079 596.4
20.8
39%
0.5
FR
Pharnext SCA
OTC:PNEXF
33 873 393.2
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.7
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.9
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.3
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.9
10%
1
US
E
Epizyme Inc
F:EPE
2 079.8
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
6%
0.9
AU
CSL Ltd
ASX:CSL
3.6
5%
0.7
NL
argenx SE
XBRU:ARGX
14.6
49%
0.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.4
46%
0.4
P/E Multiple
Earnings Growth PEG
CN
RemeGen Co Ltd
HKEX:9995
Average P/E: 191
Negative Multiple: -49
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 995.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
170.7
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.1
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.5
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -530.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
9%
2
AU
CSL Ltd
ASX:CSL
18.7
11%
1.7
NL
argenx SE
XBRU:ARGX
34.4
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 210.8
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
RemeGen Co Ltd
HKEX:9995
Average EV/EBITDA: 39.8
Negative Multiple: -55.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 499.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.5
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.1
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.1
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -577.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
NL
argenx SE
XBRU:ARGX
59.4
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
159.1
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
RemeGen Co Ltd
HKEX:9995
Average EV/EBIT: 45.9
Negative Multiple: -55.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 268.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.1
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.2
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -562.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.1
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
NL
argenx SE
XBRU:ARGX
61
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
192.9
N/A N/A